Overview of dreadful consequences of SARS-CoV-2 invasion in Italy from March 2020 to March 2022.
COVID-19 pandemic
Geographical distribution
Infected and death cases
Italy
National Health System and Service
Journal
Bulletin of the National Research Centre
ISSN: 2522-8307
Titre abrégé: Bull Natl Res Cent
Pays: Germany
ID NLM: 101755158
Informations de publication
Date de publication:
2022
2022
Historique:
received:
04
05
2022
accepted:
13
06
2022
entrez:
27
6
2022
pubmed:
28
6
2022
medline:
28
6
2022
Statut:
ppublish
Résumé
The unpredicted pandemic disease COVID-19 first flared up adversely in Europe by imparting interminable force of infected and fatality cases to Italy. In late February 2020, the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in northern Italy and swiftly proliferated to the entire country, albeit continuous to date (23 March 2022) with a lesser extent of deadliness. Current review focused on the invasions and the associated consequences by SARS-CoV-2 during the period of March 2020-March 2022. Initially, the lethality and transmissibility of the novel virus made Italy stunned within 1 month, the number of death cases reached 12,428 at the end of March 2020. The Italian Government announced an immediate emergency phase in entire country, educational institutions to local businesses, manufacturing works, cultural activities to elective activities were rescinded and all the hospitals to morgues were swamped, ensuing that fear of epidemic was impended. Besides, the Italian National Health System and Service coordinated massive public health interventions and conferred unprecedented efforts to limit the high mortality rate of the first wave of infection. Amidst 2 years of epidemic (as of 23 March 2022), Italy has documented 14,070,450 (23.74% of the population) confirmed infected cases, 12,685,306 (21.41% of the population) healed cases, 158,254 death cases (0.27% of the population) and ranking 9th worldwide in the number of deaths. Based on publicly available Italian Ministry of Health COVID-19 data, current review has comprehended region-wise total infected cases, death cases and healed cases for three consecutive years 2020-2022 to foresee different patterns of the regional outbreak and gradual subservience. At a glance, we highlighted the overview of the exhaustion and exertion of COVID-19 crisis throughout the periods in Italy.
Sections du résumé
Background
UNASSIGNED
The unpredicted pandemic disease COVID-19 first flared up adversely in Europe by imparting interminable force of infected and fatality cases to Italy. In late February 2020, the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in northern Italy and swiftly proliferated to the entire country, albeit continuous to date (23 March 2022) with a lesser extent of deadliness. Current review focused on the invasions and the associated consequences by SARS-CoV-2 during the period of March 2020-March 2022.
Main body of the abstract
UNASSIGNED
Initially, the lethality and transmissibility of the novel virus made Italy stunned within 1 month, the number of death cases reached 12,428 at the end of March 2020. The Italian Government announced an immediate emergency phase in entire country, educational institutions to local businesses, manufacturing works, cultural activities to elective activities were rescinded and all the hospitals to morgues were swamped, ensuing that fear of epidemic was impended. Besides, the Italian National Health System and Service coordinated massive public health interventions and conferred unprecedented efforts to limit the high mortality rate of the first wave of infection. Amidst 2 years of epidemic (as of 23 March 2022), Italy has documented 14,070,450 (23.74% of the population) confirmed infected cases, 12,685,306 (21.41% of the population) healed cases, 158,254 death cases (0.27% of the population) and ranking 9th worldwide in the number of deaths.
Short conclusion
UNASSIGNED
Based on publicly available Italian Ministry of Health COVID-19 data, current review has comprehended region-wise total infected cases, death cases and healed cases for three consecutive years 2020-2022 to foresee different patterns of the regional outbreak and gradual subservience. At a glance, we highlighted the overview of the exhaustion and exertion of COVID-19 crisis throughout the periods in Italy.
Identifiants
pubmed: 35756396
doi: 10.1186/s42269-022-00867-0
pii: 867
pmc: PMC9207835
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
176Informations de copyright
© The Author(s) 2022.
Déclaration de conflit d'intérêts
Competing interestsThe authors declared that they have no conflict of interest.
Références
Front Public Health. 2021 Mar 12;9:632043
pubmed: 33777885
J Clin Med. 2020 May 21;9(5):
pubmed: 32455807
BMC Psychiatry. 2021 Oct 15;21(1):509
pubmed: 34654389
Arch Microbiol. 2021 Jul;203(5):1943-1951
pubmed: 33682075
Curr Microbiol. 2022 May 5;79(6):184
pubmed: 35508737
Science. 2021 Apr 9;372(6538):
pubmed: 33658326
Int J Environ Res Public Health. 2020 Nov 24;17(23):
pubmed: 33255181
Euro Surveill. 2020 Dec;25(50):
pubmed: 33334397
Nat Commun. 2021 Jul 27;12(1):4570
pubmed: 34315899
Proc Natl Acad Sci U S A. 2020 May 12;117(19):10484-10491
pubmed: 32327608
Infect Dis (Lond). 2021 May;53(5):370-375
pubmed: 33560897
Front Public Health. 2020 Dec 08;8:588852
pubmed: 33364225
Cureus. 2020 Mar 26;12(3):e7423
pubmed: 32337143
Biomed J. 2020 Aug;43(4):328-333
pubmed: 32387617
Front Public Health. 2021 Jul 16;9:701638
pubmed: 34336776
Int J Environ Res Public Health. 2022 Jan 14;19(2):
pubmed: 35055746
Int J Environ Res Public Health. 2020 Dec 18;17(24):
pubmed: 33352883
Clin Psychol Psychother. 2021 Nov;28(6):1334-1345
pubmed: 34255890
Euro Surveill. 2020 May;25(19):
pubmed: 32431289
J Infect. 2021 Jul;83(1):e32-e33
pubmed: 33932448
J Neurovirol. 2020 Dec;26(6):834-837
pubmed: 32901393
Health Syst Transit. 2014;16(4):1-168
pubmed: 25471543
Sci Total Environ. 2021 Jan 1;750:141711
pubmed: 32835962
Front Sociol. 2020 Oct 16;5:575791
pubmed: 33869502
J Am Coll Nutr. 2020 Nov-Dec;39(8):677-684
pubmed: 33064066
Front Public Health. 2021 Jul 16;9:669209
pubmed: 34336767
Int J Antimicrob Agents. 2020 Jun;55(6):106006
pubmed: 32371096
Bull Natl Res Cent. 2022;46(1):96
pubmed: 35431535
Front Psychiatry. 2020 Aug 07;11:790
pubmed: 32848952
JACC Case Rep. 2020 Jul 15;2(9):1414-1418
pubmed: 32835287
Health Policy. 2021 Sep;125(9):1179-1187
pubmed: 34366171
Virusdisease. 2020 Dec;31(4):441-449
pubmed: 32905186
J Med Virol. 2020 Oct;92(10):1956-1961
pubmed: 32314804
Front Med (Lausanne). 2020 Apr 30;7:185
pubmed: 32426362
Front Psychol. 2021 Nov 04;12:648419
pubmed: 34803788
Am J Public Health. 2002 Jan;92(1):30, 32-3
pubmed: 11772753
J Med Virol. 2020 May;92(5):518-521
pubmed: 32022275
JAMA. 2020 May 12;323(18):1775-1776
pubmed: 32203977
Health Econ Policy Law. 2022 Jan;17(1):1-13
pubmed: 33663622
BMC Public Health. 2021 Nov 11;21(1):2069
pubmed: 34763690
BMC Oral Health. 2020 Jul 10;20(1):200
pubmed: 32650753
Lancet Public Health. 2020 May;5(5):e253
pubmed: 32220653
Virol J. 2021 Aug 14;18(1):168
pubmed: 34391446